Back to mobile site

UPDATE: Cowen Downgrades Aduro Biotech (ADRO) to Market Perform

January 10, 2020 4:34 AM EST Send to a Friend
(Updated - January 10, 2020 4:44 AM EST)

(updating comment)Cowen analyst Chris Shibutani downgraded Aduro Biotech (NASDAQ: ADRO) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login